Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

726
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
726
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

689
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
689
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

1.0K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.0K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

1.1K
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
1.1K
Bone Remodeling01:40

Bone Remodeling

34.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the Puzzle of Bone Health in Klinefelter Syndrome: Association Between DXA-Derived Lumbar Bone Strain Index and Body Composition Parameters in a Single Center Cohort.

Clinical endocrinology·2025
Same author

Artificial intelligence for predicting the risk of bone fragility fractures in osteoporosis.

European radiology experimental·2025
Same author

Usefulness of DXA-based bone strain index in postmenopausal women with type 2 diabetes mellitus.

Archives of osteoporosis·2024
Same author

Generation and Validation of Normative, Age-Specific Reference Curves for Bone Strain Index in Women.

Diagnostics (Basel, Switzerland)·2024
Same author

Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.

Endocrine reviews·2024
Same author

The relationship between bone strain index, bone mass, microarchitecture and mechanical behavior in human vertebrae: an ex vivo study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.2K

Managing osteoporosis in ulcerative colitis: something new?

Luca Petruccio Piodi1, Alessandro Poloni1, Fabio Massimo Ulivieri1

  • 1Luca Petruccio Piodi, Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico of Milan, 2 Gastroenterology Unit, 20122 Milan, Italy.

World Journal of Gastroenterology
|October 24, 2014
PubMed
Summary

Managing osteoporosis in ulcerative colitis (UC) involves assessing vitamin D and calcium, encouraging physical activity, and avoiding risk factors like smoking. Fracture risk assessment (FRAX) guides treatment decisions for UC patients to prevent fragility fractures.

Keywords:
Bone mineral densityDual energy X-ray absorptiometryFracture assessment risk toolFragility fractureHip structural analysisOsteoporosisTrabecular bone scoreUlcerative colitis

More Related Videos

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
03:56

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention

Published on: April 26, 2024

1.5K

Related Experiment Videos

Last Updated: Apr 21, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.2K
Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
03:56

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention

Published on: April 26, 2024

1.5K

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Rheumatology

Background:

  • Ulcerative colitis (UC) patients face an increased risk of bone damage and osteoporosis.
  • Management of bone health in UC requires a comprehensive approach addressing nutritional, lifestyle, and pharmacological factors.

Purpose of the Study:

  • To review current evidence on managing osteoporosis in ulcerative colitis (UC) patients.
  • To highlight strategies for preventing and treating bone damage in UC.

Main Methods:

  • Literature review of the latest evidence on osteoporosis management in UC.
  • Assessment of vitamin D status and supplementation strategies.
  • Evaluation of calcium intake, physical activity, and risk factor modification (smoking, alcohol).
  • Utilizing the Fracture Risk Assessment Tool (FRAX) for risk stratification.
  • Consideration of bone mineral density (BMD) assessment and bone quality indices (trabecular bone score, hip structural analysis).

Main Results:

  • Early assessment of vitamin D status and appropriate supplementation are crucial.
  • Adequate calcium intake, physical activity, and avoidance of risk factors are recommended.
  • FRAX tool aids in determining the need for BMD assessment and treatment.
  • Pharmacological treatment for osteoporosis in UC is generally indicated for fragility fractures or high fracture risk, especially after prolonged corticosteroid use.
  • Bisphosphonates are the most studied pharmacological option, but long-term use requires careful consideration of potential side effects.

Conclusions:

  • Primary prevention of fragility fractures is the most cost-effective strategy for UC patients.
  • A multifaceted approach including lifestyle modifications, risk factor management, and targeted pharmacological therapy based on fracture risk assessment is essential.
  • Further research is needed on optimal treatment duration and indications for specific patient groups, particularly younger individuals.